Biologics and Biosimilars Congress: Asia is organized by Global Engage Sdn Bhd - Asia Pacific Office and will be held from Nov 27 - 28, 2018 at Singapore.
The Biologics & Biosimilar Congress theme will feature cutting-edge research on topics such as modern antibody-based therapeutics & engineering, immunotherapy, and protein biotherapeutics. Also, technological advancements such as antibody-drug conjugates (ADCs), success in monoclonal antibody (Mab) and antibody-derived therapeutics for chronic diseases.
The biosimilars theme explores biosimilar projects growth in Asia. The expert speakers share their insights on development strategies, market access, and commercialisation success. This will allow you, the industries leaders and researchers to track progress and changes in the regulatory environment, clinical trials, and biomanufacturing process. Biosimilars are gaining momentum and prominence as the patents of big branded drugs lapse and cost-cutting initiatives in the healthcare sector.
This conference is part of Global Engage’s successful Drug Discovery series which includes our Precision Medicine, Medicinal Chemistry, and Synthetic Biology congresses.
This two-day interactive meeting is a unique opportunity for you to keep up to date on research breakthroughs, regulatory movements and preparing for patent cliffs and disputes through a series of stimulating dialogues.
Additional details will be posted as soon as they are available.
+60 3 2117 5193
|Registration Type||End Date||Price|
|Academic/Hospital/NFP - Fee||26 Nov,2018||USD 695.00|
|Industry - Fee||26 Nov,2018||USD 1295.00|
|Solution Provider - Fee||26 Nov,2018||USD 1695.00|